# Víctor M. Montori

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/victor-m-montori/

## Facts

| Field | Value |
| --- | --- |
| Citations | 116,622 |
| Field | Patient-Provider Communication in Healthcare |
| h-index | 151 |
| i10-index | 598 |
| Last Known Institution | Mayo Clinic |
| OpenAlex ID | https://openalex.org/A5114376236 |
| ORCID iD | https://orcid.org/0000-0003-0595-2898 |
| Works | 1,079 |

## Researcher papers

Showing 12 of 26.

- [CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials](https://scholariq.org/papers/consort-2010-explanation-and-elaboration-updated-guidelines-for-reporting/)
- [GRADE guidelines: 4. Rating the quality of evidence—study limitations (risk of bias)](https://scholariq.org/papers/grade-guidelines-4-rating-the-quality-of-evidence-study-limitations-risk-of-bias/)
- [GRADE guidelines 6. Rating the quality of evidence—imprecision](https://scholariq.org/papers/grade-guidelines-6-rating-the-quality-of-evidence-imprecision/)
- [The Diagnosis of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline](https://scholariq.org/papers/the-diagnosis-of-cushing-s-syndrome-an-endocrine-society-clinical-practice/)
- [Anti-TNF Antibody Therapy in Rheumatoid Arthritis and the Risk of Serious Infections and Malignancies](https://scholariq.org/papers/anti-tnf-antibody-therapy-in-rheumatoid-arthritis-and-the-risk-of-serious/)
- [CONSORT 2010 explanation and elaboration: Updated guidelines for reporting parallel group randomised trials](https://scholariq.org/papers/consort-2010-explanation-and-elaboration-updated-guidelines-for-reporting-3/)
- [Metabolic Syndrome and Risk of Incident Cardiovascular Events and Death](https://scholariq.org/papers/metabolic-syndrome-and-risk-of-incident-cardiovascular-events-and-death/)
- [CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials](https://scholariq.org/papers/consort-2010-explanation-and-elaboration-updated-guidelines-for-reporting-2/)
- [Patient engagement in research: a systematic review](https://scholariq.org/papers/patient-engagement-in-research-a-systematic-review/)
- [Grading quality of evidence and strength of recommendations for diagnostic tests and strategies](https://scholariq.org/papers/grading-quality-of-evidence-and-strength-of-recommendations-for-diagnostic-tests/)
- [Diagnostic performance of body mass index to identify obesity as defined by body adiposity: a systematic review and meta-analysis](https://scholariq.org/papers/diagnostic-performance-of-body-mass-index-to-identify-obesity-as-defined-by-body/)
- [Management of Hyperglycemia in Hospitalized Patients in Non-Critical Care Setting: An Endocrine Society Clinical Practice Guideline](https://scholariq.org/papers/management-of-hyperglycemia-in-hospitalized-patients-in-non-critical-care/)

## Researcher topics

- [Patient-Provider Communication in Healthcare](https://scholariq.org/topics/patient-provider-communication-in-healthcare/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Meta-analysis and systematic reviews](https://scholariq.org/topics/meta-analysis-and-systematic-reviews/)
- [Diabetes Management and Education](https://scholariq.org/topics/diabetes-management-and-education/)
- [Chronic Disease Management Strategies](https://scholariq.org/topics/chronic-disease-management-strategies/)

## Researcher university

- [Mayo Clinic](https://scholariq.org/institutions/mayo-clinic/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.